An observational study in Glaucoma, sponsored by Wills Eye. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-05.
Sponsored by Wills Eye · Observational
To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.
This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers.
The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.
1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.
This study's enrollment of 50 is below the median of 103 across 454 observational studies indexed under Glaucoma.
Browse Glaucoma studies →Wills Eye is the lead sponsor of 74 studies on the registry; 3 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 10 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Glaucoma patients or care givers
Exclusion Criteria:
Glaucoma patients and caregivers will complete a 20 item questionnaire providing demographic information, glaucoma eye drop compliance, interest in medication reminders, availability to smartphone, tablet and social media technology and interest in using a glaucoma application on social media.
Device: Interest in medical education through social media
Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Also known as: Glaucoma App Interest
Patients Owning Smartphone/Tablet Technology
Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time frame: 1 hour
Patients Having Access to Social Media Via Smartphone or Tablet in the Home
Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time frame: 1 hour
Glaucoma Medication Compliance
Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
Time frame: 1 hour
Use of Medication Reminder
Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
Time frame: 1 hour
Glaucoma patients and Caregivers were recruited from the Glaucoma Service at Wills Eye Hospital, Philadelphia, PA, USA.
| Milestone | Glaucoma Patients and Caregivers |
|---|---|
| Started | 50 |
| Completed | 50 |
| Not completed | 0 |
Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
| Participants | Glaucoma Smartphone Application |
|---|---|
| Patients Owning Smartphone/Tablet Technology | 34 |
Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
| Participants | Glaucoma Smartphone Application |
|---|---|
| Patients Having Access to Social Media Via Smartphone or Tablet in the Home | 39 |
Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
| Participants | Glaucoma Smartphone Application |
|---|---|
| Glaucoma Medication Compliance | 25 |
Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
| Participants | Glaucoma Smartphone Application |
|---|---|
| Use of Medication Reminder | 28 |
Collected over 1 hour. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Glaucoma Smartphone Application | 0/50 (0%) | 0/50 (0%) | 0/50 (0%) |
Fifty participants agreed to answer questions in the survey.
| Age, Categorical(Participants) | Glaucoma Patients and Caregivers |
|---|---|
| <=18 years | 1 |
| Between 18 and 65 years | 32 |
| >=65 years | 17 |
| Sex: Female, Male(Participants) | Glaucoma Patients and Caregivers |
|---|---|
| Female | 32 |
| Male | 18 |
| Race (NIH/OMB)(Participants) | Glaucoma Patients and Caregivers |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 2 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 9 |
| White | 33 |
| More than one race | 3 |
| Unknown or Not Reported | 3 |
| Region of Enrollment(participants) | Glaucoma Patients and Caregivers |
|---|---|
| United States | 50 |
Plan to share: No
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wills Eye